E-therapeutics Appoints Non-Executive Chair
This article was originally published in Scrip
E-therapeutics has appointed Iain Ross to its board of directors as non-executive chair and acting chair Malcolm Young has stepped down, continuing his role as CEO. Ross brings more than 35 years' experience to e-Therapeutics and is currently non-executive director Anatara LifeSciences Ltd., non-executive chair of Premier Veterinary Group plc. and Biomer Technology Ltd. Previously, Ross held roles in Sandoz, Hoffman La Roche and Celltech Group plc., where he was CEO.